PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
|
25655951 |
2015 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
|
23716570 |
2013 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations.
|
19449432 |
2009 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders.
|
10332040 |
1999 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders.
|
10441568 |
1999 |
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
PEROXISOME BIOGENESIS DISORDER 11B
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
|
25655951 |
2015 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
|
23716570 |
2013 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations.
|
19449432 |
2009 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations.
|
19449432 |
2009 |
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Peroxisome biogenesis disorders
|
0.540 |
GeneticVariation
|
group |
BEFREE |
Mutations in PEX13 and other peroxin proteins are associated with Zellweger syndrome spectrum (ZSS) disorders, a subtype of peroxisome biogenesis disorder characterized by prominent neurological, hepatic, and renal abnormalities leading to neonatal death.
|
27827795 |
2017 |
Peroxisome biogenesis disorders
|
0.540 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Peroxisome biogenesis disorders
|
0.540 |
Biomarker
|
group |
CTD_human |
Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations.
|
19449432 |
2009 |
Peroxisome biogenesis disorders
|
0.540 |
Biomarker
|
group |
CTD_human |
Taken together, these results provide strong evidence that mutations in PEX13 are responsible for disease in patient PBD222 and, by extension, in complementation group 13 of the PBDs.
|
10441568 |
1999 |
Peroxisome biogenesis disorders
|
0.540 |
Biomarker
|
group |
CTD_human |
We now have evidence that the complete human cDNA encoding Pex13p, an SH3 protein of a docking factor for the peroxisome targeting signal 1 receptor (Pex5p), rescues peroxisomal matrix protein import and its assembly in fibroblasts from PBD patients of complementation group H. In addition, we detected mutations on the human PEX13 cDNA in two patients of group H. A severe phenotype of a ZS patient (H-02) was homozygous for a nonsense mutation, W234ter, which results in the loss of not only the SH3 domain but also the putative transmembrane domain of Pex13p.
|
10332040 |
1999 |
Peroxisome biogenesis disorders
|
0.540 |
GeneticVariation
|
group |
BEFREE |
Taken together, these results provide strong evidence that mutations in PEX13 are responsible for disease in patient PBD222 and, by extension, in complementation group 13 of the PBDs.
|
10441568 |
1999 |
Peroxisome biogenesis disorders
|
0.540 |
GeneticVariation
|
group |
BEFREE |
Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders.
|
10332040 |
1999 |
Peroxisome biogenesis disorders
|
0.540 |
AlteredExpression
|
group |
BEFREE |
We examined the ability of PEX13 expression to rescue the peroxisomal protein import defects of fibroblast cells representing all known PBD complementation groups.
|
9878256 |
1998 |
Adrenoleukodystrophy, Neonatal
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Our previous study of a NALD patient with a marked deterioration by a fever revealed a mutation (Ile326Thr) within a SH3 domain of PEX13 protein (Pex13p), showing a temperature-sensitive (TS) phenotype in peroxisomal biogenesis.
|
16006427 |
2005 |